On December 2020-12, 10, China Venture Capital Research Institute "11 China (Shenzhen) Venture Capital Summit Forum CVCF" was held in Shenzhen. With the theme of "Gathering Capital Power to Promote the New Pattern of Dual Circulation", this forum brought together the venture capital industry circles to listen to the most powerful voices under the severe situation of severe global economic recession and uncertain economic growth prospects.

 

At the same time, the summit grandly announced the "CVCRI2020 China Venture Capital - Golden Investment Award" series of lists, which were broadcast live online by the China Venture Capital Research Institute and the world's largest investment platform - Dubai International Investment Annual Conference in the United Arab Emirates AIM to more than 160 countries around the world, committed to creating the most influential venture capital list.

 

 

New Value Capital was awarded

- Top 2020 Best Healthcare Investment Institutions in China in 30

- Top 2020 Growth VC Investment Institutions in China in 10

 

 

Mr. Jia Junxin, Chairman of New Value Capital, attended the summit as the special chairman and presided over the roundtable forum of "The Great Battle of the Great Health Industry".

 

 

Since 2005, China Venture Capital Research Institute has been deeply cultivating in the field of venture capital for more than dozens of spring and autumn years, relying on profound research background and huge market research data, through data analysis, performance evaluation, industry influence and other levels of strict screening, dedicated to creating the "China Venture Capital Annual List - Golden Investment Award List", aiming to commend investment institutions and investors who have made major breakthroughs and outstanding contributions to China's venture capital industry and created social benefits.

 

China Venture Capital Forum is the most influential high-end forum in China's venture capital industry initiated by Cheng Siwei, a well-known economist and former vice chairman of the Standing Committee of the National People's Congress, and is the only industry event approved by the State Council in the field of venture capital in China, and a banner in China's venture capital field.